Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study

被引:225
作者
Battaglia, J [1 ]
Moss, S [1 ]
Rush, J [1 ]
Kang, J [1 ]
Mendoza, R [1 ]
Leedom, L [1 ]
Dubin, W [1 ]
McGlynn, C [1 ]
Goodman, L [1 ]
机构
[1] ALASKA PSYCHIAT INST,ANCHORAGE,AK
关键词
haloperidol; lorazepam; psychotic agitation; rapid tranquilization;
D O I
10.1016/S0735-6757(97)90119-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rapid tranquilization is a routinely practiced method of calming agitated psychotic patients by use of neuroleptics, benzodiazepines, or both in combination, Although several studies have examined the efficacy of the three approaches, none have compared these treatments in a prospective, randomized, double-blind, multicenter trial. Ninety eight psychotic, agitated, and aggressive patients (73 men and 25 women) were prospectively enrolled during an 18-month period in emergency departments in five university or general hospitals. Patients were randomly assigned to receive intramuscular injections of lorazepam (2 mg), haloperidol (5 mg), or both in combination, Patients in each treatment group received 1 to 6 injections of the same study drug within 12 hours, based on clinical need, They were evaluated hourly after the first injection until at least 12 hours after the last. Efficacy was assessed on the Agitated Behavior Scale (ABS), a modified Brief Psychiatric Rating Scale (MBPRS), Clinical Global Impressions (CGI) scale, and an Alertness Scale. Effective symptom reduction was achieved in each treatment group with significant (P < .01) mean decreases from baseline at every hourly ABS evaluation. Significant (P < .05) mean differences on the ABS (hour 1) and MBPRS (hours 2 and 3) suggest that tranquilization was most rapid in patients receiving the combination treatment, Study event incidence (side effects) did not differ significantly between treatment groups, although patients receiving haloperidol alone tended to have more extrapyramidal system symptoms, The superior results produced by the combination treatment support the use of lorazepam plus haloperidol as the treatment of choice for acute psychotic agitation. (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:335 / 340
页数:6
相关论文
共 50 条
  • [21] Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol - A double-blind multicenter trial
    Kuenzel, Heike E.
    Ackl, Nibal
    Hatzinger, Martin
    Held, Katja
    Holsboer-Trachsler, Edith
    Ising, Marcus
    Kaschka, Wolfgang
    Kasper, Siegfried
    Konstantinidis, Anastasios
    Sonntag, Annette
    Uhr, Manfred
    Yassouridis, Alexander
    Holsboer, Florian
    Steiger, Axel
    JOURNAL OF PSYCHIATRIC RESEARCH, 2009, 43 (07) : 702 - 710
  • [22] Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study
    Devlin, John W.
    Roberts, Russel J.
    Fong, Jeffrey J.
    Skrobik, Yoanna
    Riker, Richard R.
    Hill, Nicholas S.
    Robbins, Tracey
    Garpestad, Erik
    CRITICAL CARE MEDICINE, 2010, 38 (02) : 419 - 427
  • [23] DOUBLE-BLIND COMPARATIVE-STUDY OF REMOXIPRIDE AND HALOPERIDOL IN ACUTE SCHIZOPHRENIC-PATIENTS
    DENBOER, JA
    RAVELLI, DP
    HUISMAN, J
    OHRVIK, J
    VERHOEVEN, WMA
    WESTENBERG, HGM
    PSYCHOPHARMACOLOGY, 1990, 102 (01) : 76 - 84
  • [24] Cholesterol and cognition in schizophrenia: A double-blind study of patients randomized to clozapine, olanzapine and haloperidol
    Krakowski, Menahem
    Czobor, Pal
    SCHIZOPHRENIA RESEARCH, 2011, 130 (1-3) : 27 - 33
  • [25] A MULTICENTER DOUBLE-BLIND COMPARATIVE TRIAL OF FLUVOXAMINE VERSUS LORAZEPAM IN MIXED ANXIETY AND DEPRESSION TREATED IN GENERAL-PRACTICE
    LAWS, D
    ASHFORD, JJ
    ANSTEE, JA
    ACTA PSYCHIATRICA SCANDINAVICA, 1990, 81 (02) : 185 - 189
  • [26] REMOXIPRIDE IN ACUTE-PSYCHOSIS - INTRAMUSCULAR FOLLOWED BY ORAL TREATMENT COMPARED TO HALOPERIDOL, A DOUBLE-BLIND, MULTICENTER TRIAL
    KAHN, JP
    LAXENAIRE, M
    BURNAT, G
    ALBARET, C
    HOLM, AC
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1994, 9 (02) : 79 - 92
  • [27] Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: Results of the Japan multicenter, double-blind olanzapine trial
    Ishigooka, J
    Inada, T
    Miura, S
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 55 (04) : 403 - 414
  • [28] A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lozarepam in the chemical restraint of violent and severely agitated patients
    Nobay, F
    Simon, BC
    Levitt, MA
    Dresden, GM
    ACADEMIC EMERGENCY MEDICINE, 2004, 11 (07) : 744 - 749
  • [29] Haloperidol in the acute treatment of migraine: A randomized, double-blind, placebo-controlled study
    Honkaniemi, J
    Liimatainen, S
    Rainesalo, S
    Sulavuori, S
    HEADACHE, 2006, 46 (05): : 781 - 787
  • [30] Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial
    Edmée JM Schrijver
    Oscar J de Vries
    Astrid Verburg
    Karola de Graaf
    Pierre M Bet
    Peter M van de Ven
    Ad M Kamper
    Sabine HA Diepeveen
    Sander Anten
    Andrea Siegel
    Esther Kuipéri
    Anne M Lagaay
    Rob J van Marum
    Astrid M van Strien
    Leo Boelaarts
    Douwe Pons
    Mark HH Kramer
    Prabath WB Nanayakkara
    BMC Geriatrics, 14